Moderna Inc. reported a wider-than-expected fourth-quarter loss on Wednesday, as the biotech company grapples with declining COVID-19 vaccine sales and ongoing restructuring costs. The vaccine maker ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.